Internal Medicine, Endocrinology, Diabetes, & Metabolism · Hamilton, NJ
NPI
1275573321
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1374 Whitehorse Hamilton Square Rd Ste 104
Hamilton, NJ, 08690
Phone (609) 585-4267
Groups this clinician bills Medicare through
Medicare paid, 2024
$76K
917 services
Medicare patients, 2024
199
Average age 69
Drug cost, 2024
$2.2M
7,373 prescriptions
Company payments, 2025
$1,578
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Syed W Rizvi was code 99214 (office e&m - established), 526 times for 188 patients. In total Syed W Rizvi billed 917 services in 10 codes, and Medicare paid $76K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-05-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 526 | 188 | $96.29 | $51K |
| 96372 Injection Administration | Office | 129 | 17 | $11.17 | $1,440 |
| 93922 Duplex Scan - Extremity Arteries | Office | 77 | 72 | $70.72 | $5,445 |
| 95923 Electrical Nerve Conductivity | Office | 52 | 52 | $103.24 | $5,368 |
| 95921 Electrical Nerve Conductivity | Office | 52 | 52 | $66.37 | $3,451 |
| 95250 Test - Miscellaneous | Office | 39 | 21 | $119.28 | $4,652 |
| 99204 Office E&M - New | Office | 37 | 37 | $122.79 | $4,543 |
By year: 2022 $60K for 880 services; 2023 $77K for 894 services; 2024 $76K for 917 services.
Medicare prescription drug claims, 2024
In 2024, the drug Syed W Rizvi prescribed most often to Medicare patients was Levothyroxine Sodium, with 601 prescriptions and refills. In total Syed W Rizvi wrote 7,373 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 601 | 1,226 | 128 | $4,912 |
| Ozempic Semaglutide | 396 | 564 | 76 | $519K |
| Glimepiride Generic | 370 | 805 | 87 | $3,426 |
| Metformin Hcl Generic | 364 | 804 | 112 | $2,580 |
| Jardiance Empagliflozin | 358 | 532 | 75 | $300K |
| Synthroid Levothyroxine Sodium | 292 | 584 | 46 | $20K |
| Acarbose Generic | 242 | 478 | 61 | $12K |
| Gabapentin Generic | 221 | 407 | 63 | $3,555 |
| Pioglitazone Hcl Generic | 221 | 458 | 63 | $2,186 |
| Farxiga Dapagliflozin Propanediol | 211 | 309 | 42 | $166K |
| Repaglinide Generic | 208 | 422 | 50 | $5,088 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 176 | 373 | 61 | $16K |
| Simvastatin Generic | 168 | 370 | 45 | $1,085 |
| Testosterone Cypionate Generic | 151 | 224 | 42 | $4,645 |
| Atorvastatin Calcium Generic | 139 | 346 | 49 | $1,001 |
Brand drugs: 2,933 claims; generic drugs: 4,051 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Syed W Rizvi $1,578 ($1,578 in general payments such as food, travel and fees) from 19 companies. The largest payer was Ascendis Pharma Endocrinology Inc with $281.
| Company | Payments | Amount |
|---|---|---|
| Ascendis Pharma Endocrinology Inc ASND | 17 | $281 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 10 | $168 |
| Amneal Pharmaceuticals LLC AMRX | 8 | $143 |
| Xeris Pharmaceuticals, Inc. | 9 | $139 |
| Corcept Therapeutics CORT | 7 | $130 |
| Amgen Inc. AMGN | 7 | $120 |
| CeQur Corporation | 1 | $113 |
| Insulet Corporation PODD | 5 | $108 |
| Medtronic, Inc. MDT | 2 | $56.28 |
| Dexcom, Inc. DXCM | 2 | $43.27 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.